DYCILL Drug Patent Profile
✉ Email this page to a colleague
When do Dycill patents expire, and what generic alternatives are available?
Dycill is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in DYCILL is dicloxacillin sodium. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dycill
A generic version of DYCILL was approved as dicloxacillin sodium by TEVA on June 3rd, 1982.
Summary for DYCILL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| Patent Applications: | 1,085 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DYCILL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DYCILL
US Patents and Regulatory Information for DYCILL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | DYCILL | dicloxacillin sodium | CAPSULE;ORAL | 060254-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glaxosmithkline | DYCILL | dicloxacillin sodium | CAPSULE;ORAL | 062238-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glaxosmithkline | DYCILL | dicloxacillin sodium | CAPSULE;ORAL | 062238-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Glaxosmithkline | DYCILL | dicloxacillin sodium | CAPSULE;ORAL | 060254-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
